Related Experiment Video

Updated: May 13, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

NF-κB signaling and bone resorption

Y Abu-Amer1

  • 1Department of Orthopedic Surgery, Department of Cell Biology & Physiology, Washington University School of Medicine, 660S. Euclid Avenue, Saint Louis, MO 63110, USA. abuamery@wustl.edu

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
|March 8, 2013
PubMed

Insights

Nuclear Factor-kappa B (NF-κB) signaling is crucial for skeletal development and osteoclast formation. Inhibiting NF-κB effectively reduces bone resorption, offering therapeutic targets for osteolytic diseases.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Skeletal Biology

Background:

  • Nuclear Factor-kappa B (NF-κB) is a key transcription factor family regulating cellular functions and development.
  • NF-κB signaling is integral to RANK ligand-induced osteoclastogenesis and skeletal development.
  • Dysregulation of NF-κB contributes to abnormal skeletal development and inflammatory osteolysis.

Purpose of the Study:

  • To review the role of NF-κB molecules in bone resorption.
  • To elucidate the involvement of NF-κB in inflammatory osteolysis.
  • To identify therapeutic targets for osteolytic diseases based on NF-κB pathways.

Main Methods:

  • Review of existing literature on NF-κB signaling in bone biology.
  • Analysis of studies involving genetic deletion of NF-κB pathway components in osteoclasts.
  • Examination of the interplay between NF-κB, RANKL, and inflammatory signals in bone pathology.

Main Results:

  • NF-κB signaling is essential for osteoclast formation and bone resorption.
  • Inhibition of NF-κB effectively suppresses osteoclast activity.
  • Deletion of NF-κB pathway components impairs skeletal development.
  • Inflammatory insults amplify NF-κB activity, exacerbating osteolysis.

Conclusions:

  • NF-κB is a central mediator of both physiological bone resorption and inflammatory osteolysis.
  • Targeting NF-κB components offers a promising strategy for treating osteolytic bone diseases.
  • Understanding NF-κB's role is critical for developing therapies for bone pathologies.

More Related Videos

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...